Are the FDA requirements exactly the same for generics vs name brands?

12/10/2024

Harold Robert Meyer and The ADD Resource Center

No, the FDA requirements for generic and brand-name drugs differ in several important ways, although both must adhere to strict safety standards.

Key differences include:

For brand-name drugs (New Drug Applications/NDAs):

• Must conduct extensive clinical trials to prove both safety and efficacy
• Must provide complete data about drug discovery, chemistry, manufacturing, controls, and testing
• Must submit studies showing how the drug works in the body
• Required to demonstrate therapeutic benefit

For generic drugs (Abbreviated New Drug Applications/ANDAs):

• Do not need to repeat clinical trials
• Must prove “bioequivalence” to the brand-name drug, meaning:
  • Same active ingredient
  • Same strength
  • Same dosage form
  • Same route of administration
  • Absorbed into the bloodstream at similar rate and extent
• Must show acceptable manufacturing standards and controls
• Can often rely on the brand-name drug’s safety and efficacy data
• Can only be approved after brand-name patent and exclusivity periods expire

The generic must deliver the same amount of active ingredient to the body within an acceptable range (typically 80-125% of the brand-name drug’s bioavailability). However, inactive ingredients (colors, fillers, etc.) can differ, which occasionally affects how individual patients respond to generics versus brand-name drugs.

---

© 2024 The ADD Resource Center. All rights reserved. 12/10/2024

—

Ready to Transform Your Journey? Join Our Community Today!

Discover a world of exclusive benefits and transformative content waiting for you. Our thriving community of learners and innovators is growing every day – and we’d love to have you join us! 

Not a subscriber yet?  Click Here.

For over 30 years, Harold Robert Meyer and The ADD Resource Center have provided expert ADHD support through:

• Comprehensive services for individuals, families, and organizations:
  • Personalized guidance and education
  • Behavioral intervention strategies
  • Support for healthcare providers, educators, and industry
• Evidence-based resources:
  • Informative articles and publications
  • Workshops and seminars
• Advocacy to promote understanding and reduce stigma

info@addrc.org +1 646.205.8080